Cell Culture Market Size, Share, By Product Type (Media, Instruments, Sera, and Reagents), Applications (Diagnostics, Tissue Culture & Engineering, Biopharmaceutical Production, Drug Development, and others), End-user (Academics & Research Institute, Biotechnology & Pharmaceutical Companies, Diagnostics Laboratories, and others), and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the target market is expected to increase at a rate of USD 78.9 Billion.
• In 2024, the Cell Culture Market size was estimated to be worth USD 29.25 Billion.
• The market is expanding at a 10.5% CAGR.

Cell culture is the procedure of growing cells from an open environment in a controlled laboratory environment. It plays crucial role in the life sciences, research, diagnosis, and drug testing and it is used for the study of cell biochemistry, metabolism, diseases, identify pathogens viruses, and others. The cells can directly be taken from the tissue and grow in a suitable vessel with medium that provides nutrients, growth factors, and hormones. The cell culture market include the industries that involves tools, media, and equipment used to grow cells in a suitable container and the cell culture market is driven by the increasing demand for new drug discovery and development, along with increasing investment from governments and private organizations.

For instance, in August 2024, Nucleus Biologics, a cell culture media company introduced QuickStat Media, a new media of cell culture aimed to enhancing speed and flexibility of cell culture experiments based on advanced scientific research. This is beneficial for the drug discovery and cell therapy development.

Key Takeaways:

• North America is the dominating region in the target market due to the rising advancement in laboratory technique, and biology, biotechnology techniques.
• By media type, the serum-based media plays crucial role in cell culture market as they are rich in source of amino acids, proteins, and others.

Key Drivers of Target Market:

Increasing Fundings for Cell Research to Drive the Cell Culture Market Growth

The cell culture involves developing products for diseases, such as cancer and cardiovascular conditions. The cell culture research is funded by research institute, organization, and government grants, such as Medical Research Future Fund, National Institutes of Health, and New York State Stem Cell Initiative.

• For instance, January 2024, University of Bristol spinout CellVoyant, has raised USD 7.8 Million (£7.6) in seed funding, which used AI imaging technology to help stem cell therapy to manufacture new treatments. 

Rising Demand for Chronic Disease Treatment is Expected to Propel Market Expansion

The key factor driving the cell culture market growth is the increasing demand for treating chronic diseases in personalized way. The vast growth in pharmaceutical and biotechnology industry will increase the demand for chronic disease research development.

• For instance, according to a research article published by Springer Nature Limited in 2024, this article highlights the protocol to produce highly qualified Insulin Producing Cells (IPCs) derived from human Adipose Tissue Derived Stem Cells (ADSCs). ADSCs can improve insulin sensitivity and enhance insulin secretion through various pathways, thereby alleviating diabetes and its complications.

Restraints:

Contamination during Handling Disrupts the Target Market Growth

While handling, aseptic conditions should be followed to reduce contamination. It is important to limit biological contamination as they can alter phonotype and genotype of cultured cell lines. Contamination can also occur from nutrients or toxic by-products.

• Counterbalance Statements: It is significant to train cell culture laboratory supervisors to identify early and try to prevent the spread of contaminants to other cells and products.

Opportunities & Market Trends:

Manufacturing Biotechnological Products and Viral Vaccines enhances target Market Opportunity

The mass culture of animal cells can used in manufacturing viral vaccines by growing the cells the artificial environment and in aseptic conditions. Viral vaccines which are produced from cell culture are hepatitis, rubella, chickenpox and others. Cell culture is widely used for manufacturing biotechnological products such as enzymes, hormones and antibodies. Cell culture also used in areas of biotechnology like toxicology, drug development and others.

The cell culture market is distributed into product, application, end-user, and region.

Product:

by product type, the cell culture market is categorized into, media [natural media, synthetic media, serum-based media, serum-free media, chemically defined media, and others], instruments [co2 incubators, biological safety cabinets, centrifuges, automated cell counters, cold storage, cell imaging microscope, and others], sera [fetal bovine serum and others], and reagents [albumin, hormones, amino acids, growth factors, and others]. The cell culture media segment holds a dominant cell culture market share over other segments as it is important factor for the cell culture growth. An increase in biopharmaceutical products, expanding biotechnological industry can contribute to the market growth.

• For instance, October 2021, Thermo Fisher Scientific, Inc., introduced the Gibco Cell Therapy System as NK-Xpander Medium. This medium is designed to support the growth and expansion of natural killer cells. It provides necessary nutrients and growth factors to the NK cells and the NK cells used as the production factor in clinical application.

Application:

Cell culture market, by application is segmented into diagnostics, tissue culture & engineering, biopharmaceutical production, drug development, and others. Biopharmaceutical production application of cell culture technique is expanding into the market due to the rising treatment of various types of disorders globally. Use of mammalian cell lines and plant cells in production of biopharmaceuticals can increase the demand for medicines, which increase the target market growth.

End-User:

Academics & research institute, biotechnology & pharmaceutical companies, diagnostics laboratories, and others are the end-user segments for the cell culture market. The biotechnology & pharmaceutical companies segment is dominant due to the increasing demand for the cell culture-based vaccines. Viral vaccines help to boost immune system of human against the infections.

• For instance On 6 January 2025, Merck, a leading science and technology company, announced acquisition of HUB Organoids Holding B.V. HUB’s organoid offering complements company’s cell culture portfolio of media, reagents, and bench top instrumentation. This acquisition helps Merck researchers for looking to leverage the power of 3D cell culture to understand the impact of drug response earlier in the development process.

  Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This is the dominant region in the cell culture market and is expected to continue growing in future years. The advancement in laboratory techniques is also driven by the presence of prominent companies including Thermo fisher Scientific Inc, Cytiva, and others. These companies are continuously launching their new products to remain competitive in life sciences field.

• For instance, in October 2024, Sapio Sciences, the science-aware lab informatics platform, announced that Ellison Institute of Technology Los Angeles (EIT Los Angeles), a leading interdisciplinary research center focused on cancer and global health, has successfully deployed Sapio Sciences' Laboratory Information Management System (LIMS) to streamline its complex research operations and accelerate scientific discovery.

Asia Pacific:  This is the second leading region for development in the life science field. The growth is attributed to the countries, such as India and China, witnessing growing number of cases related to cancer, further driving the market expansion in the region.

Cell Culture Market Report Scope:

Segmentation:

By Product:

• Media

• Natural Media
• Synthetic Media
•  Serum-based Media
• Serum-free Media
• Chemically Defined Media
• Others

• Instruments

• Biological safety Cabinets
• CO2 Incubators
• Centrifuges, Automated Cell Counters
•  Cold Storage
• Cell Imaging Microscope
• others

• Sera

• Fetal Bovine Serum
• Others

• Reagents
  • Albumin
  • Hormones
  • Amino Acids
  • Growth Factors
  • others

By Application:

• Diagnostics
• Tissue Culture & Engineering
• Biopharmaceutical Production
• Drug Development
• Others

By End-User:

• Academics & Research Institute,
• Biotechnology& Pharmaceutical companies
• Diagnostics Laboratories
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the cell culture market include Sartorius AG, Danaher, Merck KGaA and others. Key players operating in market are introducing new innovation in cell culture to reduce chronic disorder, toxological applications, solutions on cancer, and new drug discoveries, to maintain competitiveness in the market.

List of Key Players in the Market:

• Sartorius AG
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Corning Inc.
• Avantor, Inc.
• Bio-Techne
• PromoCell GmbH
• BD
• HiMedia Laboratories
• Corning Incorporated
• Sartorius CellGenix GmbH
• FUJIFILM Irvine Scientific
• Agilent Technologies, Inc.
• Cell Applications, Inc.

• In July 2023, the TheraPro CHO Media System was launched by Lonza, which is specially designed to enhance production of therapeutic proteins and monoclonal antibodies. The cell line GS-CHO is processed with cell culture to achieve higher concentration of proteins in biopharmaceutical manufacturing. Additionally, these will increase the demand for antibody-based therapeutics by reducing production timelines.

Analyst View:

Since the COVID-19 pandemic, great changes have been occurred in the biopharmaceuticals and biotechnology techniques and production. Increase in demand for cost effective medicine, the cell culture is a cost effective and highly efficient alternative in which the products are manufactured by using different cell culture media and reagents. Also, cell culture is widely used in research laboratories, drug development, and diagnostics labs, which are further expected to drive market growth over the forecast period.

More Related Reports

Cell Cryopreservation Market
CAR-T Cell Therapy Market
Cell and Gene Therapy Manufacturing Market
Biopharmaceutical and Biomedicine Market
India Biopharmaceutical Market